Authors:
Lowry, PW
Franklin, CL
Weaver, AL
Szumlanski, CL
Mays, DC
Loftus, EV
Tremaine, WJ
Lipsky, JJ
Weinshilboum, RM
Sandborn, WJ
Citation: Pw. Lowry et al., Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide, GUT, 49(5), 2001, pp. 656-664
Citation: Kl. Mcbride et al., Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency, J PED H ONC, 22(5), 2000, pp. 441-445
Authors:
Yan, L
Szumlanski, CL
Rice, SR
Sobell, JL
Lachman, HM
Weinshilboum, RM
Citation: L. Yan et al., Histamine N-methyltransferase functional polymorphism: Lack of associationwith schizophrenia, AM J MED G, 96(3), 2000, pp. 404-406
Authors:
Yan, L
Zhang, SC
Eiff, B
Szumlanski, CL
Powers, M
O'Brien, JF
Weinshilboum, RM
Citation: L. Yan et al., Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotypecorrelation analysis, CLIN PHARM, 68(2), 2000, pp. 210-219
Authors:
Lewis, LD
Benin, A
Szumlanski, CL
Otterness, DM
Lennard, L
Weinshilboum, RM
Nierenberg, DW
Citation: Ld. Lewis et al., Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction (vol 62, pg 464, 1997), CLIN PHARM, 67(4), 2000, pp. 431-431
Citation: Rm. Weinshilboum et al., Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase, ANN R PHARM, 39, 1999, pp. 19-52
Citation: Pw. Lowry et al., Balsalazide and azathioprine or 6-mercaptopurine: Evidence for a potentially serious drug interaction, GASTROENTY, 116(6), 1999, pp. 1505-1506